Ignite Creation Date:
2024-05-06 @ 7:22 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02515747
Status:
COMPLETED
Last Update Posted:
2015-08-05
First Post:
2015-05-08
Brief Title:
Prospective Russian Evaluation of Lpa Role in cardiovascUlar DiseasE
Sponsor:
Russian Cardiology Research and Production Center
Organization:
Russian Cardiology Research and Production Center
Study Overview
Official Title:
Role of Lipoproteina Concentration and Apolipoproteina Phenotype in Prediction of Coronary Events in General Population
Status:
COMPLETED
Status Verified Date:
2015-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PRELUDE
Brief Summary:
The purpose of this study is to explore the role of lipoproteina and apolipoproteina phenotype in fatal and non-fatal cardiovascular disease CVD events risk in coronary disease patients divided on the basis of management strategy - medical endovascular or open cardiac surgery
Detailed Description:
Between January 1993 and September 2006 we enrolled 1400 consecutive patients from the Atherosclerosis Department with known Lpa levels and coronary heart disease CHD verified by angiography In accordance with clinical condition and angiography data were assigned them into three parallel treatment arms and followed up to 15 years This study was conducted according to the principles of the Declaration of Helsinki and the Institutional Ethics Committee
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None